IJCBDD, an International Society of Intelligent Biological Medicine official journal, bridges the gap between two very important, complementary disciplines, computational biology and drug design. Through advances in high-throughput genome sequencing and digital imaging technologies, biocomputing, drug design and medical research have unfolded new, predictive sciences such as genomics, proteomics, lipidomics, metabolomics, cytomics and pharmaconomics. These promote new computational, statistical and biomedical approaches to drug design/development, besides unleashing the potential of significantly more accurate, effective personalised diagnosis, therapeutics and patient care.
Journal Home: Journal Homepage
Editor-in-Chief: Dr. Zhongming Zhao
scope: Big data analysis and tools for biological and medical data Drug screening, drug discovery, drug design and re-purposing Biomolecular dynamics, biomolecular/phylogenetic databases Cellular signalling/communications, cell engineering, molecular/cellular systems Computational epigenetics and functional genomics Computational approaches in virus omics and drug targets Machine learning, deep learning, data mining and knowledge discovery
Print ISSN: 1756-0756
Electronic ISSN: 1756-0764
Abstracting and Indexing: Scopus
Imapct Factor :
Subject Area and Category: Computer Science,Computer Science Applications,Pharmacology, Toxicology and Pharmaceutics,Drug Discovery
Publication Frequency:
H Index: 14
Q1:
Q2:
Q3:
Q4: Drug Discovery
Cite Score: 0.6
SNIP: 0.102
Journal Rank(SJR): 0.145
Guidelines for Authors: International Journal of Computational Biology and Drug Design Author Guidelines
Publisher: Inderscience Enterprises Ltd
Country: United Kingdom
